Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action modulators |
Mechanism fibrin modulators(Fibrin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 2 | United States | 29 Mar 2022 | |
| Pulmonary Embolism | Phase 1 | United States | 13 May 2019 | |
| Venous Thromboembolism | Phase 1 | United States | 13 May 2019 | |
| Venous Thrombosis | Phase 1 | United States | 13 May 2019 | |
| Atrial Fibrillation | Phase 1 | United States | 01 Apr 2016 | |
| COVID-19 | Phase 1 | United States | 01 Apr 2016 | |
| Thrombosis | Phase 1 | United States | 01 Apr 2016 |





